<mods xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" ID="P0b002ee1d0bed1cd">
    <name type="corporate">
         <namePart>United States Government Publishing Office</namePart>
         <role>
              <roleTerm authority="marcrelator" type="text">publisher</roleTerm>
              <roleTerm authority="marcrelator" type="code">pbl</roleTerm>
        </role>
         <role>
              <roleTerm authority="marcrelator" type="text">distributor</roleTerm>
              <roleTerm authority="marcrelator" type="code">dst</roleTerm>
        </role>
    </name>
    <name type="corporate">
         <namePart>United States</namePart>
         <namePart>Congress</namePart>
         <namePart>House of Representatives</namePart>
         <role>
              <roleTerm authority="marcrelator" type="text">author</roleTerm>
              <roleTerm authority="marcrelator" type="code">aut</roleTerm>
        </role>
         <description>Government Organization</description>
    </name>
    <typeOfResource>text</typeOfResource>
    <genre authority="marcgt">government publication</genre>
    <language>
         <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
    </language>
    <extension>
         <collectionCode>BILLS</collectionCode>
         <searchTitle>To amend the Controlled Substances Act to clarify that the possession, sale, purchase, importation, exportation, or transportation of drug testing equipment that tests for the presence of fentanyl or xylazine is not unlawful.;Safeguarding Testing and Overdose Prevention Against Fentanyl and Xylazine Act;STOP Fentanyl and Xylazine Act;H.R. 1563 (IH)
    </searchTitle>
         <category>Bills and Statutes</category>
         <waisDatabaseName>119_cong_bills</waisDatabaseName>
         <branch>legislative</branch>
         <dateIngested>2025-03-17</dateIngested>
    </extension>
    <titleInfo>
         <title>To amend the Controlled Substances Act to clarify that the possession, sale, purchase, importation, exportation, or transportation of drug testing equipment that tests for the presence of fentanyl or xylazine is not unlawful.</title>
    </titleInfo>
    <titleInfo type="alternative">
         <title>Safeguarding Testing and Overdose Prevention Against Fentanyl and Xylazine Act</title>
    </titleInfo>
    <titleInfo type="alternative">
         <title>STOP Fentanyl and Xylazine Act</title>
    </titleInfo>
    <titleInfo type="alternative">
         <title>H.R. 1563 (IH)
    </title>
    </titleInfo>
    <originInfo>
         <publisher>U.S. Government Publishing Office</publisher>
         <dateIssued encoding="w3cdtf">2025-02-25</dateIssued>
         <issuance>monographic</issuance>
    </originInfo>
    <physicalDescription>
         <note type="source content type">deposited</note>
         <digitalOrigin>born digital</digitalOrigin>
         <extent>2 p.</extent>
    </physicalDescription>
    <classification authority="sudocs">Y 1.6:</classification>
    <classification authority="sudocs">Y 1.4/6:</classification>
    <identifier type="local">P0b002ee1d0bed1cd</identifier>
    <identifier type="uri">https://www.govinfo.gov/app/details/BILLS-119hr1563ih</identifier>
    <identifier type="preferred citation">H.R. 1563</identifier>
    <identifier type="stock number">021-610-00252-9</identifier>
    <identifier type="Parent ILS system id">000501532</identifier>
    <identifier type="Child ILS system id">000325573</identifier>
    <identifier type="Parent ILS title">Congressional bills</identifier>
    <identifier type="Child ILS title">House bills</identifier>
    <identifier type="former package identifier">f:h1563_ih.txt</identifier>
    <location>
         <url displayLabel="Content Detail" access="object in context">https://www.govinfo.gov/app/details/BILLS-119hr1563ih</url>
         <url displayLabel="HTML rendition" access="raw object">https://www.govinfo.gov/content/pkg/BILLS-119hr1563ih/html/BILLS-119hr1563ih.htm</url>
         <url displayLabel="PDF rendition" access="raw object">https://www.govinfo.gov/content/pkg/BILLS-119hr1563ih/pdf/BILLS-119hr1563ih.pdf</url>
         <url displayLabel="XML rendition" access="raw object">https://www.govinfo.gov/content/pkg/BILLS-119hr1563ih/xml/BILLS-119hr1563ih.xml</url>
    </location>
    <accessCondition type="GPO scope determination">fdlp</accessCondition>
    <recordInfo>
         <recordContentSource authority="marcorg">DGPO</recordContentSource>
         <recordCreationDate encoding="w3cdtf">2025-03-17</recordCreationDate>
         <recordChangeDate encoding="w3cdtf">2025-03-17</recordChangeDate>
         <recordIdentifier source="DGPO">BILLS-119hr1563ih</recordIdentifier>
         <recordOrigin>machine generated</recordOrigin>
         <languageOfCataloging>
              <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
        </languageOfCataloging>
    </recordInfo>
    <name type="personal">
         <namePart>Jasmine Crockett</namePart>
         <affiliation>United States House of Representatives</affiliation>
         <role>
              <roleTerm authority="marcrelator" type="text">sponsor</roleTerm>
              <roleTerm authority="marcrelator" type="code">spn</roleTerm>
        </role>
         <description>United States Congress Member</description>
    </name>
    <name type="personal">
         <namePart>Lance Gooden</namePart>
         <affiliation>United States House of Representatives</affiliation>
         <role>
              <roleTerm type="text">cosponsor</roleTerm>
        </role>
         <description>United States Congress Member</description>
    </name>
    <name type="corporate">
         <namePart>United States</namePart>
         <namePart>Congress</namePart>
         <namePart>House of Representatives</namePart>
         <namePart>Committee on Energy and Commerce</namePart>
         <role>
              <roleTerm authority="marcrelator" type="text">associated name</roleTerm>
              <roleTerm authority="marcrelator" type="code">asn</roleTerm>
        </role>
    </name>
    <name type="corporate">
         <namePart>United States</namePart>
         <namePart>Congress</namePart>
         <namePart>House of Representatives</namePart>
         <namePart>Committee on the Judiciary</namePart>
         <role>
              <roleTerm authority="marcrelator" type="text">associated name</roleTerm>
              <roleTerm authority="marcrelator" type="code">asn</roleTerm>
        </role>
    </name>
    <relatedItem type="isReferencedBy">
         <titleInfo>
              <title>United States Code</title>
              <partNumber>Title 21 Section 863</partNumber>
        </titleInfo>
         <identifier type="USC citation">21 U.S.C. 863</identifier>
    </relatedItem>
    <extension>
         <docClass>hr</docClass>
         <accessId>BILLS-119hr1563ih</accessId>
         <congress>119</congress>
         <session>1</session>
         <originChamber>HOUSE</originChamber>
         <currentChamber>HOUSE</currentChamber>
         <billNumber>1563</billNumber>
         <billVersion reprint="false">ih</billVersion>
         <fileSuffix>ih</fileSuffix>
         <shortTitle type="measure">Safeguarding Testing and Overdose Prevention Against Fentanyl and Xylazine Act</shortTitle>
         <shortTitle type="measure">STOP Fentanyl and Xylazine Act</shortTitle>
         <officialTitle>To amend the Controlled Substances Act to clarify that the possession, sale, purchase, importation, exportation, or transportation of drug testing equipment that tests for the presence of fentanyl or xylazine is not unlawful.</officialTitle>
         <action date="2025-02-25">Ms. Crockett (for herself and Mr. Gooden) introduced the following bill; which was referred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned</action>
         <congCommittee authorityId="hsif00" chamber="H" congress="119" type="S">
                                
              <name type="authority-standard">Committee on Energy and Commerce</name>
                                
              <name type="authority-short">Energy and Commerce</name>
                            
        </congCommittee>
         <congCommittee authorityId="hsju00" chamber="H" congress="119" type="S">
                                
              <name type="authority-standard">Committee on the Judiciary</name>
                                
              <name type="authority-short">Judiciary</name>
                            
        </congCommittee>
         <congMember bioGuideId="C001130" chamber="H" congress="119" party="D" role="SPONSOR" state="TX">
                                
              <name type="parsed">Ms. Crockett</name>
                                
              <name type="authority-fnf">Jasmine Crockett</name>
                                
              <name type="authority-lnf">Crockett, Jasmine</name>
                            
        </congMember>
         <congMember bioGuideId="G000589" chamber="H" congress="119" party="R" role="COSPONSOR" state="TX">
                                
              <name type="parsed">Mr. Gooden</name>
                                
              <name type="authority-fnf">Lance Gooden</name>
                                
              <name type="authority-lnf">Gooden, Lance</name>
                            
        </congMember>
         <isPrivate>false</isPrivate>
         <isAppropriation>false</isAppropriation>
         <USCode title="21">
                                
              <section number="863"></section>
                            
        </USCode>
    </extension>
</mods>